178 related articles for article (PubMed ID: 30770789)
1. PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.
Baek JH; Yun HS; Kwon GT; Lee J; Kim JY; Jo Y; Cho JM; Lee CW; Song JY; Ahn J; Kim JS; Kim EH; Hwang SG
Cell Death Dis; 2019 Feb; 10(3):156. PubMed ID: 30770789
[TBL] [Abstract][Full Text] [Related]
2. PLOD3 promotes lung metastasis via regulation of STAT3.
Baek JH; Yun HS; Kwon GT; Kim JY; Lee CW; Song JY; Um HD; Kang CM; Park JK; Kim JS; Kim EH; Hwang SG
Cell Death Dis; 2018 Nov; 9(12):1138. PubMed ID: 30442941
[TBL] [Abstract][Full Text] [Related]
3. PLOD3 regulates the expression of YAP1 to affect the progression of non-small cell lung cancer via the PKCδ/CDK1/LIMD1 signaling pathway.
Li WH; Huang K; Wen FB; Cui GH; Guo HZ; Zhao S
Lab Invest; 2022 Apr; 102(4):440-451. PubMed ID: 35039611
[TBL] [Abstract][Full Text] [Related]
4. Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer.
Hsu HY; Lin TY; Lu MK; Leng PJ; Tsao SM; Wu YC
Sci Rep; 2017 Mar; 7():44990. PubMed ID: 28332554
[TBL] [Abstract][Full Text] [Related]
5. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
6. PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.
Wang B; Xu L; Ge Y; Cai X; Li Q; Yu Z; Wang J; Wang Y; Lu C; Wang D; Wang Y; Chen X; Gu Y
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775879
[TBL] [Abstract][Full Text] [Related]
7. IRE1α-TRAF2-ASK1 pathway is involved in CSTMP-induced apoptosis and ER stress in human non-small cell lung cancer A549 cells.
Zhang J; Liang Y; Lin Y; Liu Y; YouYou ; Yin W
Biomed Pharmacother; 2016 Aug; 82():281-9. PubMed ID: 27470364
[TBL] [Abstract][Full Text] [Related]
8. A synthetic podophyllotoxin derivative exerts anti-cancer effects by inducing mitotic arrest and pro-apoptotic ER stress in lung cancer preclinical models.
Chen JY; Tang YA; Li WS; Chiou YC; Shieh JM; Wang YC
PLoS One; 2013; 8(4):e62082. PubMed ID: 23646116
[TBL] [Abstract][Full Text] [Related]
9. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
11. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
12. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
13. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
14. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
[TBL] [Abstract][Full Text] [Related]
15. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
Zhang B; Liu ZM; Hao FG; Wang M
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
[TBL] [Abstract][Full Text] [Related]
16. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
[TBL] [Abstract][Full Text] [Related]
17. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.
Qin S; Zhang B; Xiao G; Sun X; Li G; Huang G; Gao X; Li X; Wang H; Yang C; Ren H
Tumour Biol; 2016 Oct; 37(10):13509-13520. PubMed ID: 27465556
[TBL] [Abstract][Full Text] [Related]
19. A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway.
Wang Y; Xiao J; Zhou H; Yang S; Wu X; Jiang C; Zhao Y; Liang D; Li X; Liang G
J Med Chem; 2011 Jun; 54(11):3768-78. PubMed ID: 21504179
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
